Skip to content

Clinical trials

Polycystic Ovary Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycystic Ovary Syndrome Country / region: China Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20101
20111
20126
20132
20142
20155
20169
20173
20186
20199
20209
20217
20228
20239
202410
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status46
Completed37
Recruiting13
Not yet recruiting5
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital11
Heilongjiang University of Chinese Medicine10
Shanghai 10th People's Hospital10
RenJi Hospital8
Shanghai Zhongshan Hospital5
Peking Union Medical College Hospital4
Bing He3
Guangdong Women and Children Hospital3
Jiangxi University of Traditional Chinese Medicine3
The First Affiliated Hospital of Guangzhou Medical University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycystic Ovary Syndrome105
Insulin Resistance13
Obesity11
Infertility7
Overweight5
Diabetes, Gestational2
Infertility, Female2
Ovarian Hyperstimulation Syndrome2
Anxiety Disorders1
Bipolar Disorder1

Trials

Showing 76 to 100 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.